Stephen D. Steinour, who serves as President, CEO, and Chairman of Huntington Bancshares (HBAN), has maintained a strictly one-sided posture in his open-market activity: he has bought and never sold. Across 43 total Form 4 filings spanning two companies, his cumulative purchases total roughly $599,500, with zero open-market sales or issuer buybacks recorded. The most recent conviction trade came on March 12, 2026, when he spent $499,970.73 on HBAN shares—a sizable outlay that dwarfs his other discretionary purchase of $99,528.50 in BBWI (Bath & Body Works) on November 21, 2025. That BBWI transaction, his only other open-market buy in the window, signals a modest diversification of conviction beyond his primary employer.
The remainder of Steinour’s filing history is dominated by non-discretionary or compensatory events. Recurring “A” codes—grants and awards with zero dollar value—appear monthly on HBAN, typically on the first of the month, alongside periodic “M” option exercises and corresponding “F” tax-withholding sales. For instance, on February 6, 2026, he exercised options valued at $2.515 million but simultaneously had $3.478 million in shares withheld to cover taxes, a net reduction that is automatic rather than a bearish signal. Similarly, a March 9, 2026 exercise of $254,648.78 was paired with a $3.118 million tax withholding. The only gift on record, a December 8, 2025 transfer of HBAN shares, carried no monetary value.
The pattern is unambiguous: Steinour’s only deliberate capital deployment has been into the market, with his largest single purchase—roughly $500,000 in HBAN—coming just weeks before his most recent grant cycle. The absence of any “S” or “D” codes across his entire filing history, combined with the mechanical nature of his “F” and “M” transactions, suggests a consistent accumulation bias rather than periodic profit-taking. His most recent filings, all “A” grants with zero value, indicate ongoing compensation alignment rather than new cash commitments.
AI-assisted summary